Login to Your Account

APNS Partners With Lilly For Early Stage Alzheimer's Work

By Jennifer Boggs

Wednesday, November 29, 2006
Applied NeuroSolutions Inc. (APNS) will receive $2 million up front in an early stage partnership with Eli Lilly and Co. focused on developing drugs targeting an underlying cause of Alzheimer's disease. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription